Preconditioning the Ocular Surface with UCMSC-Derived Exosomes Preserves Corneal Integrity in Experimental Dry Eye
Pharmaceutics · 16.11.2026 · 18 (11) · 1480
DOI: 10.3390/pharmaceutics18111480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 16.11.2026. Verfasst von Sze-Min Chan und 4 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Dry eye disease (DED) disrupts corneal epithelial homeostasis and may cause progressive ocular surface injury. Although MSC-derived exosomes have shown therapeutic efficacy after the establishment of DED, their prophylactic potential remains unclear. This study evaluated whether topical UCMSC-derived exosome preconditioning protects the cornea against subsequent aqueous-deficient DED.
Methods
Forty female Sprague-Dawley rats aged six to eight weeks were allocated to the prophylactic exosome treatment (PTE) or untreated control groups. PTE rats received low-concentration UCMSC-derived exosome eye drops once daily for 14 days before unilateral lacrimal gland excision; treatment ceased immediately after surgery. Clinical, AS-OCT, histological, ZO-1, Ki-67, and TUNEL assessments were conducted before induction and through Day 14. Corneal TNF-α, IL-1β, TGF-β, and IL-10 expression was measured via qPCR at Day 0.
Results
PTE reduced overall corneal neovascularization (mean vessel length, 46.91 vs. 117.06 µm; p = 0.015) and epithelial thickening (54.01 vs. 71.80 µm; p = 0.006). ZO-1 immunoreactivity was significantly greater in the PTE group (D14: 0.678 vs. 0.154; p < 0.001), while there were significantly fewer TUNEL-positive cells at D0 (17.5 vs. 59.5; p < 0.001) and D7 (16.25 vs. 57.25; p < 0.001). Fluorescein staining, stromal thickness, Ki-67 immunoreactivity, and cytokine transcription did not differ significantly between groups.
Conclusions
Preconditioning with topical UCMSC-derived exosomes conferred selective corneal protection after dosing ended, characterized by reduced angiogenesis and apoptosis and better preservation of epithelial thickness and tight-junction integrity. These findings support prophylactic exosome exposure as a proof-of-concept strategy for enhancing corneal resilience before predictable ocular surface injury in this severe experimental model; however, the absence of a vehicle-treated control and limited mechanistic characterization warrant further investigation before clinical translation.
Zitieren
APA
Chan, S., Tsai, C., Lee, T., Huang, Z., & Lin, C. (2026). Preconditioning the Ocular Surface with UCMSC-Derived Exosomes Preserves Corneal Integrity in Experimental Dry Eye. Pharmaceutics, 18(11), 1480. https://doi.org/10.3390/pharmaceutics18111480
Vancouver
Chan S, Tsai C, Lee T, Huang Z, Lin C. Preconditioning the Ocular Surface with UCMSC-Derived Exosomes Preserves Corneal Integrity in Experimental Dry Eye. Pharmaceutics. 2026;18(11):1480. doi:10.3390/pharmaceutics18111480
BibTeX
@article{Chan2026,
author = {Chan, Sze-Min and Tsai, Chris and Lee, Tai-Ping and Huang, Zih-Rou and Lin, Chung-Tien},
title = {Preconditioning the Ocular Surface with UCMSC-Derived Exosomes Preserves Corneal Integrity in Experimental Dry Eye},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {11},
pages = {1480},
doi = {10.3390/pharmaceutics18111480}
}
EUVIMED